Jean-jacques G. Martin

Antwerpen, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Spatio-temporal Kriging for spatial irradiance estimation with short-term forecasting in a thermosolar power plant.

Spatio-temporal Kriging for spatial irradiance estimation with short-term forecasting in a thermosolar power plant.

Journal: Heliyon

Published: November 19, 2023

Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.

Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.

Journal: Journal of Alzheimer's disease : JAD

Published: November 07, 2022

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

Hippocampal Sclerosis in Frontotemporal Dementia: When Vascular Pathology Meets Neurodegeneration.

Journal: Journal of neuropathology and experimental neurology

Published: February 27, 2021

Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.

Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia.

Journal: Neurobiology of aging

Published: November 30, 2020

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease.

Journal: Acta neuropathologica communications

Published: October 21, 2020

Amyloid-β1-43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations.

Amyloid-β1-43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations.

Journal: Alzheimer's research & therapy

Published: July 10, 2020

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.

Mutated ATP10B increases Parkinson's disease risk by compromising lysosomal glucosylceramide export.

Journal: Acta neuropathologica

Published: December 07, 2019

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects.

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects.

Journal: Journal of Alzheimer's disease : JAD

Published: March 19, 2019

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

Journal: Acta neuropathologica

Published: December 03, 2018

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.

Monoaminergic impairment in Down syndrome with Alzheimer's disease compared to early-onset Alzheimer's disease.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: May 22, 2018

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort.

Journal: Journal of Alzheimer's disease : JAD

Published: April 05, 2018

GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia.

GDAP2 mutations implicate susceptibility to cellular stress in a new form of cerebellar ataxia.

Journal: Brain : a journal of neurology

Published: December 15, 2017

Showing 1-12 of 57

Last Updated: 09/26/2026